Oral Vinorelbine (VNR) and Capecitabine (CAP) - an Acceptable and Effective Combination Chemotherapy for Early Metastatic Breast Cancer (MBC)

被引：0
|
作者：
Hogg, M. [1 ]
机构：
[1] Lancashire Teaching Hosp NHS Trust, Preston, Lancs, England
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S112 / S112
页数：1
相关论文
共 50 条
  • [41] Phase II study with the combination of capecitabine (C) and vinorelbine (V) in metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes.
    Estevez, LG
    Batista, N
    Sánchez-Rovira, P
    Velasco, A
    Domine, M
    Lobo, F
    Oramas, J
    Cruz, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 63S - 63S
  • [42] A phase II trial of oral combination chemotherapy with capecitabine and cyclophosphamide (XC) in metastatic breast cancer
    Hirata, M.
    Takao, S.
    Okamoto, Y.
    Yamashita, S.
    Kawaguchi, Y.
    Takami, M.
    Furusawa, H.
    Abe, C.
    Sakamoto, J.
    Yoshimoto, M.
    EJC SUPPLEMENTS, 2010, 8 (03): : 197 - 197
  • [43] Dose-finding study on a continuous dose of oral vinorelbine (VNR) in heavily pre-treated metastatic breast cancer (MBC) patients (pts)
    Pellegrini, D.
    Giannarelli, D.
    Ferretti, G.
    Fabi, A.
    Nistico, C.
    Cognetti, F.
    Papaldo, P.
    ANNALS OF ONCOLOGY, 2015, 26 : 15 - 15
  • [44] Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II study
    Tanaka, Maki
    Takamatsu, Yasushi
    Anan, Keisei
    Ohno, Shinji
    Nishimura, Reiki
    Yamamoto, Yutaka
    Masuda, Norikazu
    Mitsuyama, Shoshu
    Tamura, Kazuo
    ANTI-CANCER DRUGS, 2010, 21 (04) : 453 - 458
  • [45] CLINICAL IMPACT OF METRONOMIC ORAL COMBINATION CHEMOTHERAPY WITH CAPECITABINE AND CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST CANCER
    Fujihara, Miwa
    Ohtani, Shoichiro
    Ito, Mistuya
    Kajiwara, Yukiko
    Yoshimura, Yuri
    BREAST, 2015, 24 : S40 - S40
  • [46] Vinorelbine-5-fluorouracil combination as second line chemotherapy in metastatic breast cancer (MBC) after anthracycline-taxanes combination (AT).
    Girre, V
    Dalenc, F
    Laurence, V
    Jouve, M
    Diéras, V
    Pierga, JY
    Beuzeboc, P
    Extra, JM
    Pouillart, P
    ANNALS OF ONCOLOGY, 2000, 11 : 24 - 24
  • [47] Final Results of a Phase II Study of the Combination of Oral Vinorelbine (NVBo), Capecitabine (X) and Trastuzumab (H) in HER2-positive Metastatic Breast Cancer (MBC)
    Petruzelka, L.
    Ganju, V.
    Conte, P. F.
    Tubiana-Mathieu, N.
    Majois, F.
    Espie, M.
    Llombart, A.
    Gil Gil, M.
    Villanova, G.
    Chan, A.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S110 - S110
  • [48] Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC)
    Lorusso, V.
    Spada, M.
    Giampaglia, M.
    Misino, A.
    Calabrese, R.
    Latorre, A.
    Monticelli, G.
    Guida, M.
    Sambiasi, D.
    ANNALS OF ONCOLOGY, 2006, 17 : VII146 - VII146
  • [49] Primary efficacy endpoint analysis of the CARIN trial: Capecitabine (Cap) and bevacizumab (Bev) with or without vinorelbine (Vin) in first line metastatic breast cancer (MBC)
    Welt, A.
    Lerchenmiiller, C.
    Decker, T.
    Marschner, N.
    Salat, C.
    Hegewisch-Becker, S.
    CANCER RESEARCH, 2013, 73
  • [50] Simple oral therapy with capecitabine (CAPE) and cyclophosphamide (CPA) for metastatic breast cancer (MBC).
    Schott, A. F.
    Lew, D.
    Barlow, W. E.
    Albain, K. S.
    Chew, H. K.
    Wade, J. L.
    Lanier, K. S.
    Linden, H. M.
    Hortobagyi, G. N.
    Livingston, R. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345